CN Patent

CN112876510A — 一种磷酸酯类多环化合物及其药物组合物和用途

Assigned to Shijiazhuang Dikaiwei Pharmaceutical Technology Co ltd · Expires 2021-06-01 · 5y expired

What this patent protects

本发明公开了一种磷酸酯类多环化合物及其药物组合物和用途，所述磷酸酯类多环化合物如式(I)所示，其中各基团的定义详见说明书；本发明化合物是一类高效低毒、口服吸收、且生物利用度良好的抗病毒分子，可用于抗流感病毒。

USPTO Abstract

本发明公开了一种磷酸酯类多环化合物及其药物组合物和用途，所述磷酸酯类多环化合物如式(I)所示，其中各基团的定义详见说明书；本发明化合物是一类高效低毒、口服吸收、且生物利用度良好的抗病毒分子，可用于抗流感病毒。

Drugs covered by this patent

Patent Metadata

Patent number
CN112876510A
Jurisdiction
CN
Classification
—
Expires
2021-06-01
Drug substance claim
No
Drug product claim
No
Assignee
Shijiazhuang Dikaiwei Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.